title: Tyrosine kinase inhibitors in renal cell cancer: Losing an empire and yet to find a role.
authors.affiliation: University of Cambridge, Biomedical Research Campus, Cambridge, UK; AstraZeneca, Cambridge, UK. Electronic address: tgqe2@medschl.cam.ac.uk.
authors.forename: Tim
authors.initials: T
authors.lastname: Eisen
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D060890:B7-H1 Antigen / Q000037:antagonists & inhibitors*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D058990:Molecular Targeted Therapy / Q000379:methods*; D061026:Programmed Cell Death 1 Receptor / Q000037:antagonists & inhibitors*
chemical_list: D060890:B7-H1 Antigen; D061026:Programmed Cell Death 1 Receptor